期刊文献+

CD_(105)在肺癌组织中的表达及其与预后的关系

下载PDF
导出
摘要 应用免疫组织化学SP法检测CD105在70份肺癌癌组织及40份癌旁组织标本中的表达,结果CD105在癌组织中的阳性表达率明显高于癌旁组织,其表达与肺癌临床分期有关;CD105不同表达的化疗患者中位生存时间明显长于非化疗者,以化疗CD105阴性者最长;COX回归分析显示,CD105与肺癌患者的预后有关。认为CD105与肺癌的发生、发展密切相关,可作为评价肺癌预后的指标。
出处 《山东医药》 CAS 北大核心 2008年第17期65-66,共2页 Shandong Medical Journal
基金 河北省科学技术厅指导性课题项目(20042761356)
  • 相关文献

参考文献6

二级参考文献27

  • 1Saad R S, Jasnosz K M, Tung M Y, et al. Endoglin (CD105) expression in endometrial carcinoma[J].Int J Gynecol Pathol,2003,22(3):248-253.
  • 2Dales J P, Garcia S, Bonnier P, et al. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients[J]. Am J Clin Pathol,2003,119(3):374-380.
  • 3Wikstrom P, Lissbrant I F, Stattin P, et al. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer[J].Prostate,2002,51(4):268-275.
  • 4Duff S E, Li C, Garland J M, et al. CD105 is important for angiogenesis: evidence and potential applications[J].FASEB J,2003,17(9):984-992.
  • 5Yagasaki H, Kawata N, Takimoto Y, et al. Histopathological analysis of angiogenic factors in renal cell carcinoma[J].Int J Urol,2003,10(4):220-227.
  • 6Nakai S, Masaki T, Shiratori Y, et al. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival[J]. Int J Oncol. 2002,20(4):769-775.
  • 7Fonsatti E,Del Vecchio L,Altomonte M,et al. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies[J]. J Cell Physiol,2001,188(1):1-7.
  • 8Neufeld G, Cohen T,Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors[J]. FASEB J,1999,13(1):9-22.
  • 9Hirohashi S, Ishiak K G,Kojiro M, et al. Hepatocellular carcinoma[A]. Hamilton S R, Aaltonen L A. World health organization classification of tumours. Pathology and genetics of tumours of the digestive system[C]. Lyon: IARC Press,2000.159-172.
  • 10Ito Y, Takeda T, Sasaki Y, et al. Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma[J]. Liver, 2002,22(2):145-149.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部